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Oxidative stress has been associated with prostate cancer development and progression due to an 63 
increase of reactive oxygen species (ROS). However, the mechanisms whereby ROS and the 64 
antioxidant system participate in cancer progression remain unclear.  65 
In order to clarify the influence of oxidative stress in prostate cancer progression, we performed 66 
this study in two human prostate cancer cell lines, PC3 and HPV10 (from metastasis and from 67 
cancer in situ, respectively) and RWPE1 cells derived from normal prostate epithelium. Cells 68 
were treated with hydrogen peroxide (H2O2) and PC3 cells were also treated with diethyl maleate 69 
(DEM). The effect on cell growth, viability, mitochondria membrane potential and oxidative 70 
stress was analyzed. Oxidative stress was evaluated based on ROS production, oxidative lesion 71 
of lipids (MDA) and on determination of antioxidants, including enzyme activity of glutathione 72 
peroxidase (Gl-Px), glutathione reductase (Gl-Red) and on the quantification of glutathione 73 
(GSH), glutathione-s-transferase (GST) and total antioxidant status (TAS).  74 
PC3 shows higher ROS production but also the highest GSH levels and Gl-Red activity, possibly 75 
contributing to oxidative stress resistance. This is also associated with higher mitochondrial 76 
membrane potential, TAS and lower lipid peroxidation. On the other hand, we identified Gl-Red 77 
activity reduction as a new strategy in overcoming oxidative stress resistance, by inducing H2O2 78 
cytotoxicity. Therefore these results suggest Gl-Red activity reduction as a new potential 79 
therapeutic approach, in prostate cancer.  80 
 81 
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1. INTRODUCTION 92 
 93 
Prostate cancer is still the most frequently diagnosed malignant disease and the second leading 94 
cause of cancer-related mortality in men in most Western countries [1, 2]. 95 
Although the causes of the high incidence of prostate cancer are poorly understood, 96 
epidemiological, experimental and clinical studies, suggest that oxidative stress (OS) plays a 97 
major role in explaining prostate cancer development and progression [3-12]. OS, defined as an 98 
imbalance between reactive oxygen species (ROS) production and antioxidant defences [13, 14] 99 
has been linked to some prostate cancer risk factors including diet intake [15-18], recurrent 100 
inflammation and aging [19-21].  101 
ROS, generated in vivo, include free radicals and non-radicals. Free radicals are molecules 102 
containing unpaired electrons as superoxide anion (.O2-), hydroxyl radical (.OH) and peroxide 103 
radicals [22]. Non-radicals such as singlet molecular oxygen (O2), nitrogen oxide (NOx) and 104 
hydrogen peroxide (H2O2) can easily give rise to oxygen radicals. Namely, H2O2 leads to .OH 105 
formation, in the presence of transition metals [22, 23]. ROS play an essential role in signal 106 
transduction pathways [24], cell cycle progression [25-30], gene transcription [31], cell 107 
differentiation [28, 32] and death (for review see Martindale and Holbrook [33]). However, an 108 
increase in ROS production and/or a decrease in antioxidant network may induce to severe OS 109 
leading to biomolecules damage such as DNA, proteins and lipids [3-12, 34, 35]. On the other 110 
hand, oxidative damage of DNA is thought to play a critical role in all stages of carcinogenesis 111 
[36]. 112 
Moreover, the major feature of radiation therapy that is a standard treatment of prostate cancer is 113 
based in ROS generation leading to oxidative damage [37]. However, metastatic prostate cancer 114 
cells may be resistant to radiotherapy, suggesting that the antioxidant system may play an 115 
important role in circumventing radiation cytotoxicity [34], thus, contributing for therapy failure. 116 
Therefore new therapeutic approaches related, in part, with OS modulation, have been suggested, 117 
namely, by Freitas et al [38].  118 
The antioxidant network comprises the enzymes superoxide dismutase (SOD), catalase, 119 
glutathione peroxidase (Gl-Px), glutathione reductase (Gl-Red) and glutathione-s-transferase 120 
(GST) that play an important role in prostate cancer prevention, protecting cells from genomic 121 




vitamins E and C and reduced glutathione (GSH) complement the antioxidant enzymes and are 123 
capable of neutralising ROS [22]. GSH plays a critical role in cellular redox maintenance. Gl-Px 124 
catalyzes the reduction of peroxides and the formation of oxidized glutathione (GSSG) [7]. Gl-125 
Red uses NADPH and H+ to reduce the GSSG back to GSH [9]. This paper investigates whether 126 
ROS (peroxides) and antioxidant defences contribute to prostate cancer progression and how the 127 
OS modulation may be a new prostate cancer therapeutic approach. 128 
 129 
2. MATERIALS AND METHODS 130 
 131 
2.1. Cell culture conditions 132 
 133 
Human prostate cancer cell lines derived from localized adenocarcinoma, from (HPV10) [39], 134 
from bone metastasis (PC3) [40] and from the normal prostate epithelium (RWPE1) [41] were 135 
purchased from the American Type Culture Collection (ATCC) and cultured in optimum growth 136 
conditions.  137 
RWPE1 and HPV10 cells were grown in keratinocytes medium (Gibco) supplemented with 138 
5ng/ml of human recombinant epidermal growth factor (rEGF) (Gibco) and 0.05 mg/ml of 139 
bovine pituitary extract (BPE) (Invitrogen, formely Gibco-BRL). PC3 cells were grown in RPMI 140 
1640 medium (Sigma) with 10 % (v/v) heat-inactivated fetal bovine serum (FBS) (Biochrom) 141 
and 2 mM L-glutamine (Sigma). Both medium, were supplemented with 100U/ml Penicillin, 142 
100µg/ml Streptomycin and with 5µg/ml Kanamycin (Sigma). 143 
Cells were maintained in a 95% humidified incubator with 5% CO2 at 37°C and were passaged 144 
with trypsinization every fourth day. For assays RWPE1 and HPV10 were plated at a density of 145 
5x105cells/ml whereas PC3 were seeded at a density of 3x105 cells/ml. After being cultured for 146 
24h, the cells were washed once with fresh assay medium and treated for 24 to 72 hours with 147 
hydrogen peroxide (H2O2)(10nM-500µM). PC3 were also treated with diethyl maleate (DEM) 148 
(Sigma). 149 
 150 





Cell proliferation was measured by the colorimetric MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-153 
diphenyltetrazolium bromide) (Sigma) assay method that quantifies the reduction of the yellow 154 
tetrazolium salt to purple formazan crystals by the mitochondria of viable cells [42]. Briefly, 155 
untreated and treated cells were washed with PBS (Gibco) that was replaced by MTT (0.5mg/ml) 156 
supplemented with 1mM CaCl2 (Sigma). The cells were then incubated at 37ºC for 2 h. 157 
Formazan crystals were dissolved with HCl 0.04 M in isopropanol. Absorbance from the 158 
resultant coloured solution was measured at 570 nm [38]. 159 
 160 
2.3. Flow Cytometry studies 161 
 162 
Each 24h of incubation, 1 x 106 of treated cells and corresponding controls, were collected by 163 
trypsinization and washed two times in PBS buffer, by centrifugation, for further acquisition and 164 
analysis in a FACScalibur (488nm and 635nm), using the Cellquest and Paint-a-gate software 165 
(BD Bioscience). Attached cells are considered as viable and were selected for. mitochondrial 166 
membrane potential (MMP) and ROS analysis. For cell viability and death analysis we also 167 
collected the suspension cells. 168 
Specimens were prepared in triplicate and at least 10000 events were collected. 169 
 170 
2.3.1. Cell viability and death: detection of apoptosis or necrosis using Annexin 171 
V/Propidium iodide incorporation 172 
 173 
For identification of cell death by apoptosis or necrosis, suspension and attached cells were 174 
collected for the assay. After washed, the collected cells (1 x 105) were resuspended in 100µL of 175 
binding buffer (0.025 M CaCl2, 1.4 M NaCl, 0.1 M Hepes) containing 5 µL annexin-V APC and 176 
2µL propidium iodide 3µM (PI) (Invitrogen-Molecular Probes). Samples were kept in the dark at 177 
room temperature for 15 minutes, according to manufacturer’s instruction [43] and Freitas et al. 178 
[38]. 179 
 180 





In order to detect MMP, the cells were labelled with the fluorescent probe 5,5´,6,6´-tethrachloro-183 
1,1´3,3´-tetraethylbenzimidazolylcarbocyanine iodide (JC1) (Cell Technology) according to 184 
manufacture’s instructions as previously performed by Freitas et al. [38]. Briefly 5x105 cells 185 
were resuspended in 0.5 ml of 1x JC-1 reagent solution and then incubated for 15 minutes, at 186 
37ºC in a 5% CO2 chamber. The cells were washed two times with 2 ml 1 x assay buffer under 187 
centrifugation at 1500 rpm, resuspended in 0.5 ml 1x assay buffer and were analyzed by flow 188 
cytometry.   189 
The lipophilic cationic probe JC1, developed by Cossariza et al. [44] is able to selectively enter 190 
in the intact mitochondria, forming J-aggregates (J-A), which are associated with a large shift in 191 
emission (590 nm). However, in lower polarized mitochondrial membrane, JC1 accumulates in 192 
the cytoplasm in the monomeric form (J-M), emitting at 527 nm after excitation at 490 nm. 193 
Therefore the ratio J-M/ J-A is inversely correlated with MMP. 194 
 195 
2.4. OS evaluation 196 
 197 
OS was evaluated by measuring ROS production, antioxidant capacity and lipid peroxidation. 198 
 199 
2.4.1. Reactive oxygen species measurements 200 
 201 
We evaluate ROS levels by labelling 5x105 cells with 5µM 2,7 dichlorodihydrofluorescein 202 
diacetate (DCFH2-DA) (Sigma) according to adaptations of previously procedures [38, 45-47]. 203 
The cells were incubated during 1h at 37ºC, in the dark, washed 2 times in 0.5 ml phosphate-204 
buffered saline (PBS) and were collected through centrifugation at 1500 rpm. The cells were 205 
then resuspended in 0.5ml PBS for flow cytometry analyses. This methodology is based on the 206 
conversion of (DCFH2-DA) in DCFH2 by intracellular esterases and consequent formation of the 207 
highly fluorescent 2,7-dichlorofluorescein (DCF) by ROS. The resultant green fluorescence is 208 
proportional to the intracellular level of ROS, upon excitation at 488 nm. Moreover total 209 
population was considered for ROS measurements. 210 
 211 





2.4.2.1. Cell lysates preparation 214 
 215 
After 24h, treated cells were washed 2 times with PBS, scraped off the flasks and resuspended in 216 
1 ml PBS. Cells were then subjected to 3 pulses of sonication for 10 seconds with 1 minute 217 
intermittent cooling on ice in a Bandelin Sonorex. 218 
Protein concentration was assessed using bicinchonic acid assay kit (Sigma) according to 219 
manufacture’s instruction. The lysates had been stored at -80ºC before usage.  220 
 221 
2.4.2.2. Reduced glutathione assay 222 
 223 
Reduced glutahione (GSH) was performed using a kit from Oxisresearch according to 224 
manufacture’s instructions. This method is based on the formation of a chromophoric thione that 225 
is proportional to GSH concentration at 420 nm [48]. Results are expressed as µmol of GSH per 226 
gram of protein (µmol/g prot). 227 
 228 
2.4.2.3. Antioxidant enzymes determinations 229 
 230 
2.4.2.3.1. Glutathione peroxidase  231 
 232 
Glutathione peroxidase (Gl-Px) activity was evaluated by spectrophotometry using tert-233 
butylperoxide as a substrate [49], monitoring the formation of oxidized glutathione, through the 234 
quantification of the oxidation of NADPH to NADP+ at 340 nm. Results are expressed in 235 
international units of enzyme per gram of protein (U/g prot). 236 
 237 
2.4.2.3.2. Glutathione reductase  238 
 239 
Glutahtione reductase (Gl-Red) activity was determined using GSSG as a substrate and 240 
monitoring its reduction to GSH through quantification of NADPH oxidation at 340 nm [50] in a 241 
thermostatized spectrophotometer UVIKON 933 UV/ Visible, at 37ºC. Gl-Red activity was 242 





2.4.2.3.3. Glutathione-s-transferase  245 
 246 
Glutathione-s-transferase (GST) levels, namely from the Pi subgroup (GST-Pi), were quantified 247 
by an Enzyme Immuno Assay (EIA) according to manufacture’s instructions 248 
(Immunodiagnostick) at 450nm. This method is based in the competition of GST samples and 249 
GST from plate for a rabbit antibody binding. After a washing step, the detection of the bound 250 
rabbit antibody is performed by a peroxidase labeled goat antibody anti rabbit (POD-antibody). 251 
The amount of converted substrate (TMB) is indirectly proportional to the amount of GST 252 
antigen in the sample [51]. The results are expressed as µmol of GST per gram of protein 253 
(µmol/g prot). 254 
 255 
2.4.3. Lipid peroxidation evaluation 256 
 257 
Oxidative lesion of lipids was evaluated by the formation of a thiobarbituric acid (TBA) adduct 258 
of malondialdehyde (MDA) and then separated by HPLC [52, 53]. Cell lysates were boiled 259 
during 60 min with TBA and phosphoric acid, then were deproteinized with methanol / NaOH 260 
1M (10:1) and centrifuged. The supernatant (20  l) was injected into a Spherisorb ODS2 5  m 261 
(250 x 4.6mm) column. Elution was performed with 60% (v/v) potassium phosphate buffer 50 262 
mM, pH 6.8, and 40% (v/v) methanol at a flow rate of 1 ml/min. The TBA-MDA adducts were 263 
detected at 532 nm and quantified by extrapolating the area of the peaks from a calibration curve 264 
of 1,1,3,3-tetraetoxipropane (TEP) standard solutions. Results are expressed as µmol of MDA 265 
per gram of protein (µmol/g prot). 266 
 267 
2.4.4. Total Antioxidant Status (TAS) determination 268 
 269 
TAS was determined by a chromogenic method (Randox Laboratories Crumham’s, North 270 
Ireland) with briefly adaptations. This methodology is based on the capacity to inhibit the 271 
formation of the ABTS+ radical cation (2,2’-azino-di- [3-etilbenzotiazolin sulfonate]) and 272 
detection at 600 nm in a spectrophotometer UVIKON 933-UV / Visible, thermostatized and 273 





2.5. Statistics 276 
 277 
Statistical analyses were carried out using t-tests. Significance was assessed for P values<0.05. 278 
 279 
3. RESULTS 280 
 281 
3.1. Metastatic prostate cancer cells are more resistant to H2O2 then the other cell lines 282 
 283 
3.1.1. Effect of H2O2 on cell growth and viability 284 
Fig.1 represents the proliferative effect of H2O2 (10nM-500µM) on a cell line derived from 285 
human normal prostate epithelium (RWPE1) and on prostate cancer cells, derived from localized 286 
and metastatic carcinoma (HPV10 and PC3 respectively), during 72h. As we observe H2O2 287 
induces different effects according to cell type, time of incubation and concentration exposure. 288 
Therefore H2O2 inhibits RWPE1 cell growth for all tested concentrations whereas PC3 seems to 289 
maintain a cell proliferation rate above the half maximal inhibitory concentration (IC50). On the 290 
other hand we found that low H2O2 concentrations induce an increase in HPV10 cells 291 
proliferation.  292 
We observed that the effect of H2O2 on cell proliferation inhibition, namely at IC50 293 
concentration is associated to cell death mainly by necrosis, in HPV10 and RWPE1 cells. Data 294 
not shown, also indicate that lower ROS concentration, namely 100µM H2O2, induced necrosis 295 
in RWPE1 and HPV10. However, PC3 maintain cell viability besides a decrease in cell 296 
proliferation (Fig. 2). These results suggest a more efficient adaptation to peroxides in PC3.  297 
 298 
3.1.2. Influence of H2O2 on MMP 299 
To evaluate the role of mitochondria on prostate cancer progression/metastasization and the 300 
effect of H2O2 on MMP we used the JC1 assay. Fig. 3 shows that PC3 cells had the highest basal 301 
MMP and RWPE the lowest, which is in line with viability and proliferative results. However, in 302 




demonstrated by the increase of monomers/aggregates (M/A) ratio that also agree with viability 304 
and proliferative results. 305 
3.1.3. Metastatic prostate cancer cells are resistant to ROS (peroxides) by an increase in 306 
GSH content and Gl-Red activity 307 
 308 
To evaluate the role of H2O2 on ROS (peroxides) production we used the 2,7 309 
dichlorodihydrofluorescein diacetate (DCFH2-DA) probe, a dye that fluoresces in the presence of 310 
peroxides (H2O2) [46].  311 
This study shows that prostate cancer cells, particularly the metastatic cells (PC3), exhibit 312 
significant higher ROS levels compared with the others (Fig.4). On the other hand the sensitivity 313 
to cytotoxicity induced by ROS (H2O2) in RWPE1 and HPV10 is confirmed by an increase in 314 
lipid peroxidation as observed in Fig. 5. In opposite we found a decrease in lipid peroxidation 315 
and increase of TAS in PC3 (Fig. 5). These results suggest that PC3 cells are resistant to ROS 316 
which may contribute to a more aggressive phenotype, related with prostate progression and 317 
metastasization. In order to determine the contribution of the antioxidant system in cells 318 
adaptation to ROS, we analysed GSH and GST content and Gl-Red and Gl-Px activities, 319 
simultaneously in the three cell lines. Results represented in Fig. 6 indicate a significant decrease 320 
in GST (Fig. 6D) content and Gl-Px (Fig. 6B) activity in the malignant cells, particularly in PC3, 321 
which may be related with higher H2O2 levels. On the other hand, PC3 have the highest GSH 322 
content and Gl-Red activity that could contribute to resistance to OS (Fig. 6C and 6A 323 
respectively). 324 
 325 
3.1.4. Adaptation to peroxides (ROS) is reverted by DEM  326 
 327 
In order to evaluate the modulation of ROS resistance by GSH content, the major thiol in 328 
mammalian cells, and Gl-Red activity, PC3 cells were treated with a thiol depleting agent 329 
(DEM), during 24h. 330 
As we can observe in Fig. 7 (A1 and A2), DEM induces a decrease in GSH content and Gl-Red 331 
activity concomitantly with a decrease in cell proliferation (Fig. 7 B1) and an increase of 332 




In fact, the association of DEM and 500µM H2O2 induced a decrease in cell growth (Fig. 7 B2) 334 
and viability (Fig. 7C).when compared with 500µM H2O2 alone. This is accompanied by an 335 
increase in cell death mainly by apoptosis and late apoptosis/necrosis after 24h treatment with 336 
DEM (Fig. 7C). 337 
 338 
4. DISCUSSION  339 
 340 
Development of efficient therapies requires a better understanding of the mechanisms underlying 341 
prostate carcinogenesis. Although OS has been associated with prostate cancer development and 342 
progression due to an increase of ROS [7, 55], the mechanisms whereby ROS and antioxidants 343 
may induce cancer progression remain unclear [12]. As a result, greater understanding of OS 344 
may be of considerable importance for fighting prostate cancer.  345 
In line with existing literature, we observed that the effect of H2O2 on cell proliferation is dose, 346 
time and cell type dependent. In particular, low levels of H2O2 (10-100nM) induced cell growth, 347 
in HPV10, derived from localized carcinoma, suggesting that small increments of ROS may be 348 
important in progression of prostate cancer. Interestingly, Sikka et al. [7] previously 349 
demonstrated that low levels of H2O2 (30pM to 300nM), induce cell growth on benign prostate 350 
hyperplasia (BPH), characterized by an intense cell proliferation rate and considered as potential 351 
precursor of prostate cancer [56]. On the other hand, chronic inflammation of prostate 352 
epithelium, due to persistent ROS production, has been associated with increase of OS and DNA 353 
damage leading to neoplastic transformation (for a good review of this literature see Nelson et al. 354 
[19]). However, an excess of ROS is expected to be harmful and to induce apoptosis in several 355 
human tumour cell lines [19]. Here we found that 500µM H2O2 inhibits cell proliferation in all 356 
the tested cells lines, but the effect was less pronounced in PC3. These differences may be 357 
notably observed after 72h of treatment.  358 
Moreover it was accompanied by cell death, essentially by necrosis, in HPV10 and in the normal 359 
epithelium cell line, RWPE1 just after 24h treatment. Similar results were found by Sika et al. 360 
[7] in BPH cell lines with 300µM H2O2. However, higher H2O2 concentrations did not affect PC3 361 
viability that appears to be more resistant to OS. It would be interesting to evaluate whether 362 
H2O2 causes some cycle phase-specific blockade, since drug-provoked oxidative stress causes 363 




We observed the highest basal levels of ROS in PC3 (Fig. 4) which may be related to cells 365 
resistance to H2O2 induced cytotoxicity and to a more aggressive phenotype, although others 366 
have found that increase of ROS is related with cell injury, resulting from oxidative damage of 367 
biomolecules such as DNA, proteins and lipids [3-12, 34, 35]. It is also important to realize that 368 
tumor progression is based on DNA mutations which promote cancer cells proliferation and 369 
surveillance [57]. In part, these mutations may be acquired as a result of an increase of ROS 370 
which require an antioxidant system adaptation [58].  371 
Viability results are in line with MMP detected in cells. In fact, at basal conditions, PC3 cells 372 
show the highest MMP whereas RWPE1 cells show the lowest MMP. These results may be 373 
related with cell vulnerability to ROS induced cytotoxicity. In the same way, when PC3 were 374 
treated with 500µM H2O2 we didn’t observe a significant decrease in MMP, in contrast to other 375 
cell lines. Based on this evidence we also suggest that variation in MMP is related to cell growth 376 
but not in a directly proportional ratio. 377 
In order to better understand the effect of OS in prostate cancer progression we evaluated the 378 
levels of ROS and antioxidant defences among the distinct cell lines. We found that ROS levels 379 
are lower in RWPE1 and substantially higher in PC3 as we have previously referred. These 380 
findings are in agreement with those observed by Kumar et al. [55]. The same authors show that 381 
the degree of ROS generation is directly proportional to aggressive phenotype. They also found 382 
higher levels of ROS in PC3 compared to RWPE1, although, they did not analyse localized 383 
prostate cancer cell lines as performed in our work. Likewise we demonstrate that HPV10 cells 384 
show intermediate ROS levels. These cells also represent an intermediate stage (localized 385 
cancer) between RWPE1 and PC3 cells. Kumar et al. [55] also demonstrated that ROS, mainly 386 
generated by the Nox system (trans-membrane proteins called the NADPH oxidases), is essential 387 
for deregulated growth, colony formation, cell migration and invasion and contribute to tumour 388 
metastization. Besides the increase of ROS levels in PC3 cells, we found lower levels of lipid 389 
peroxidation (MDA) and higher levels of TAS that are consistent with cell resistance to OS. 390 
Therefore, these results suggest that PC3 cells counteract OS by expressing particular free radical 391 
scavengers. In fact, we found significant increase of GSH and Gl-Red activity in PC3 that may 392 
protect these cells under persistent ROS (peroxides) production, induced by radiotherapy and 393 
chemotherapy. H2O2 treatment induced a clear decrease in TAS that is in agreement with the 394 




antioxidant defences, in face of the H2O2 insult. On the other hand it may be explained by the 396 
high basal levels of GSH content and Gl-Red activity observed in PC3. However, we may 397 
consider other explanations for the observed decrease of TAS and increase of MDA. Namely, as 398 
TAS evaluation is based on the antioxidants capacity to inhibit ABTS+ radical cation (2,2’-azino-399 
di- [3-etilbenzotiazolin sulfonate])[42] and that the antioxidant system may be recruited to face 400 
the increase of H2O2, we admit that the antioxidant defences are unavailable to inhibit ABTS+, 401 
leading to TAS reduction observations. Moreover, the antioxidant system comprises other 402 
antioxidant defences like catalase, playing an important role in neutralizing H2O2, or superoxide 403 
dismutase and α-tocopherol (that protects from lipid peroxidation), which we didn’t analyzed 404 
that may also contribute to explain the decrease of TAS and increase of MDA.  405 
In contrast, Gl-Px activity and GST are depleted in PC3 suggesting that GST depletion may 406 
facilitate prostate cancer progression as described by others [8]. The same assumption may be 407 
addressed to Gl-Px activity.  408 
GSH, the major thiol in mammalian cells, maintains an optimum cellular redox potential trough 409 
the inactivation of H2O2. The contribution of GSH and Gl-Red in PC3 cells protection against 410 
ROS was also suggested by Lim et al. [9]. These authors compared two metastatic prostate 411 
cancer cells, LNCaP, and PC3 and found lower ROS levels in PC3 that could be explained by an 412 
increase of GSH content, Gl-Red, thioredoxin reductase (TR) and GST activities. However, 413 
Kumar et al. [55] contradict those results showing higher ROS levels in PC3 comparing to 414 
LNCaP. In our study, PC3 Gl-Red activity is in the range values found by Jung et al. [3]. These 415 
authors also reported an increase in Gl-Red and a decrease in GST and Gl-Px activities in 416 
metastatic prostate cancer cells (PC3, LNCaP and DU145) comparing with primary cell cultures 417 
of benign and malignant human prostatic tissue. They also show higher Gl-Px and lower Gl-Red 418 
activities in PC3 cells comparing to other metastatic cell lines, reinforcing our observations that 419 
Gl-Px is decreased and Gl-Red is increased in advanced tumours cells. Therefore Gl-Red may 420 
contribute to protection against ROS.  421 
To confirm the role of GSH content and Gl-Red activity in the adaptation to OS by metastatic 422 
prostate cancer cells, we treat the cells with DEM, a thiol depletion agent. Our study revealed 423 
that cells treated with 50µM DEM alone show a decrease in Gl-Red activity, additionally to a 424 
decrease in GSH content (Fig 7A1) with no interference on cell proliferation and death. 425 




accomplished by a decrease in cell proliferation and increase of cell death preferentially by 427 
apoptosis and late apoptosis/necrosis. GSH reduction in the presence of DEM is in agreement 428 
with the results obtained by Coffey et al. [59,60]. These authors show an increase of apoptosis 429 
induced by radiation, in the presence of DEM, in PC3 and in other metastatic prostate cancer 430 
cells, LNCaP and DU145. They also found that apoptosis is accompanied by an efflux of GSH 431 
from the nucleus to the cytosol and admit that the presence of GSH in the nucleus may offer 432 
resistance to apoptosis. 433 
Here we strongly proved that Gl-Red activity reduction participates in the increase of H2O2 434 
toxicity in metastatic prostate cancer cells, suggesting a potential therapeutic approach. It may be 435 
also related with GSH reduction as observed here and by others [59,60]. These results also 436 
conduct to the possibility of using other Gl-Red activity reducing agents or to evaluate the 437 
combined effect of DEM with conventional chemotherapeutic drugs, namely docetaxel, 438 
expecting that the association may allow to lowering drug concentrations, therefore reducing 439 
drug side effects, related with systemic toxicity. In fact we previously found that sodium 440 
selenite,a thiol depleting agent, combined with docetaxel, play a synergistic effect on PC3 cells 441 
growth inhibition and induces cell death [38] Likewise our study warrants further evaluation of 442 
oxidative stress modulation in prostate cancer therapeutic approach. In particular, it would be 443 
interesting to evaluate the effect of DEM-produced GSH depletion and Gl-Red reduced activity 444 
in the RWPE cells, in order to evaluate the potential toxicity in non tumour cells.  445 
 446 
5. CONCLUSIONS 447 
 448 
As described above, other reports have compared the relative efficacy of antioxidant system in 449 
prostate cancer. However, this work develops a more graded study by including models 450 
representative of different stages of prostate malignancy.  451 
To our knowledge, our study performed on cell lines representing normal prostate epithelium, 452 
localized and metastatic prostate cancer, all stages of prostate cancer progression, is the first 453 
demonstrating an increase of ROS (peroxides) along with prostate cancer progression, 454 
concomitantly with OS adaptation. Therefore we suggest that this duality may be necessary for 455 




as normal epithelium cell line shows lower ROS levels in basal conditions, but greater sensitivity 457 
to cytotoxicity induced by ROS (500µM H2O2) and concomitantly lower GSH levels and Gl-Red 458 
activity, these conditions may contribute to a higher susceptibility to OS lesion by normal 459 
prostate epithelium. 460 
The cell line model, presented here shows an important approach to understanding oxidative 461 
stress through the different stages of prostate cancer. However, it is possible that cell lines do not 462 
exactly reflect the true in vivo situation. We also realize that the present strategy, developed in a 463 
cell line model, may not be efficient when applied to in vivo experiments. Different culture 464 
conditions could influence the observed results. However, this study does propose oxidative 465 
stress modulation as a possible new therapeutic approach in prostate cancer. We intend to carry 466 
out further evaluation of this strategy to in vivo model. 467 
Furthermore, as far as we are aware, we are the first to confirm the pivotal role of GI-Red's 468 
activity as a new target-directed therapeutic tool in the treatment of prostate cancer. 469 
 470 
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8. FIGURE LEGENDS 687 
 688 
FIGURE 1. Dose-response curves. The effect of different H2O2 concentrations (10nM–500µM) 689 
on proliferation of human normal prostate epithelium (RWPE1) and prostate cancer cells, 690 
derived from localized and metastatic carcinoma (HPV10 and PC3) are represented. Proliferation 691 
was evaluated through the formation of formazan products by 3-(4,5-dimethylthiazol-2-yl)-2,5-692 
diphenyltetrazolium bromide (MTT), each 24h, during 72 hours of incubation, as refereed in 693 
materials and methods. Results are expressed as percentage of MTT reduction relatively to 694 
control (cells not treated with H2O2) and correspond to the mean ± SD of at least 3 separate 695 
experiments.  696 
 697 
FIGURE 2. Effect of H2O2 on cell viability and death in RWPE1, HPV10 and PC3 cells. 698 
Dot-plot profiles (1) were obtained after the acquisition of 10 000 events. Cells cultured in the 699 
absence (untreated) or in the presence of 500µM H2O2 during 24 hours. Cells were incubated 700 
with AnnexinV/IP as refereed in materials and methods. Alive cells (A) exclude propidium 701 




iodide, externalize phosphatidylserine to the outside of the plasma membrane and therefore bind 703 
Annexin V (IA) emitting fluorescence. Propidium iodide stains nuclear DNA of necrotic (N) and 704 
late apoptosis/necrosis cells (LA/N). 705 
Results were expressed as the percentage of cells staining with the respective molecular probe 706 
(2). The results represent the means ± SD of at least triplicate determinations. Significantly 707 
viability and necrosis differences are considered: ***p<0.001 vs untreated samples, ###p<0.001 708 
for PC3 and HPV10 vs RWPE1 and +++p<0.001 for PC3 vs HPV10. 709 
 710 
FIGURE 3. MMP evaluation in RWPE1, HPV10 and PC3 cells. Dot-plot profiles (1) were 711 
obtained after the acquisition of 10 000 events. RWPE1, HPV10 and PC3 cells were cultured in 712 
the absence (untreated) or in the presence of 500µM H2O2 for 24 hours. The MMP was assessed 713 
by flow cytometry labelling the cells with the molecular probes JC1 as described in materials and 714 
methods. Results were expressed as the ratio of Monomers/Aggregates (M/A) (which are 715 
inversely proportional to MMP) and represent the means MMP ± SD of at least triplicate 716 
determinations (2). Significantly viability differences are considered: ***p<0.001 vs untreated 717 
samples, ###p<0.001 and ##p<0.01 for PC3 and HPV10 vs RWPE1 and +p<0.05 for PC3 vs 718 
HPV10. 719 
 720 
FIGURE 4. Effect of H2O2 on ROS production in RWPE1, HPV10 and PC3 cells. Dot-plot 721 
profiles (1) were obtained after the acquisition of 10 000 events. RWPE1, HPV10 and PC3 cells 722 
were cultured in the absence (untreated) or in the presence of 500µM H2O2 for 24 hours. ROS 723 
was assessed by flow cytometry labelling the cells with 2,7 dichlorodihydrofluorescein diacetate 724 
(DCFH2-DA). The results were expressed as the means intensity fluorescence (MIF) ± SD of at 725 
least triplicate determinations (2). Significantly differences are considered: *p<0.05 vs untreated 726 
samples, ##p<0.01, ###p<0.001 for PC3 and HPV10 vs RWPE1 and +++p<0.001 for PC3 vs 727 
HPV10. 728 
 729 
FIGURE 5. Evaluation of lipid peroxidation and TAS in RWPE1, HPV10 and PC3 cells  730 
Cells were treated with 500µM H2O2 for 24 hours as described in materials and methods. Lipid 731 
peroxidation (A) was evaluated by MDA determination levels. MDA and TAS (B) levels were 732 




± SD of at least triplicate determinations. Significantly differences are considered: *p<0.05 vs 734 
untreated samples, #p<0.05, ## p<0.01, ###p<0.001 for HPV10 and PC3 vs RWPE1 and +p<0.05, 735 
++p<0.01 for PC3 vs HPV10. 736 
 737 
FIGURE 6. Antioxidant defences in RWPE1, HPV10 and PC3 cells. We evaluate Gl-Red (A) 738 
and Gl-Px (B) activities and GSH (C) and GST (D) content. Cells were treated with 500µM 739 
H2O2 for 24 hours as described in materials and methods. Results are expressed as the means ± 740 
SD of at least triplicate determinations. Significantly differences are considered for *p<0.05, 741 
**p<0.01 vs untreated samples, #p<0.05, ##p<0.01, and ###p<0.001 for HPV10 and PC3 vs 742 
RWPE1 and +p<0.05 and +++p<0.001 for PC3 vs  HPV10.  743 
 744 
FIGURE 7. Effect of DEM on PC3 antioxidant defences -.relation with cell proliferation 745 
and viability. GSH content (A1) and Gl-Red activity (A2) on PC3 were analysed after treating 746 
cells with 50µM DEM for 24 hours. The effect of DEM (50µM -1000µM) alone (B1) and 747 
combined with 500µM H2O2 (B2) on PC3 cells growth was evaluated during 72h. In (C) is 748 
represented the influence of DEM on PC3 cell viability and death. Cells were treated with 749 
500µM H2O2, in the absence (control) and in the presence of 50µM DEM for 24 hours. Viability 750 
was assessed by flow cytometry as previously described. Viable cells are expressed by alive cells 751 
(A), initial apoptosis by (IA), necrosis (N) and late by apoptosis/necrosis (LA/N). 752 
Results were expressed as the means ± SD of at least triplicate determinations. Significant 753 
differences are considered for *p<0.05, **p<0.01 and ***p<0.005 vs control. Cell viability and 754 
death statistical results are indicated for (IA) and (LA/N).  755 
 756 

















  Oxidative stress was evaluated on a cell line model of prostate cancer progression 762 
 763 
  Metastatic cell lines show the highest ROS, total antioxidant status and resistance to H2O2 764 
 765 
  Metastatic cell lines show the highest levels of GSH levels and Gl-Red activity  766 
 767 
  Decrease in GSH levels and Gl-Red activity induced a decrease in H2O2 resistance  768 
 769 
  Gl-Red activity reduction may be a new therapeutic approach in prostate cancer 770 
 771 
 772 
 773 
